These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
414 related articles for article (PubMed ID: 18977436)
1. The influence of the preparation methods on the inclusion of model drugs in a beta-cyclodextrin cavity. Salústio PJ; Feio G; Figueirinhas JL; Pinto JF; Cabral Marques HM Eur J Pharm Biopharm; 2009 Feb; 71(2):377-86. PubMed ID: 18977436 [TBL] [Abstract][Full Text] [Related]
2. Physicochemical characteristics and bioavailability of a novel intestinal metabolite of ginseng saponin (IH901) complexed with beta-cyclodextrin. Lee PS; Han JY; Song TW; Sung JH; Kwon OS; Song S; Chung YB Int J Pharm; 2006 Jun; 316(1-2):29-36. PubMed ID: 16574357 [TBL] [Abstract][Full Text] [Related]
3. Influence of the preparation method on the physicochemical properties of indomethacin and methyl-β-cyclodextrin complexes. Rudrangi SR; Bhomia R; Trivedi V; Vine GJ; Mitchell JC; Alexander BD; Wicks SR Int J Pharm; 2015 Feb; 479(2):381-90. PubMed ID: 25579867 [TBL] [Abstract][Full Text] [Related]
4. Comparison of ibuprofen release from minitablets and capsules containing ibuprofen: β-cyclodextrin complex. Salústio PJ; Cabral-Marques HM; Costa PC; Pinto JF Eur J Pharm Biopharm; 2011 May; 78(1):58-66. PubMed ID: 21195175 [TBL] [Abstract][Full Text] [Related]
5. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation. Badr-Eldin SM; Elkheshen SA; Ghorab MM Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829 [TBL] [Abstract][Full Text] [Related]
6. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin. Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924 [TBL] [Abstract][Full Text] [Related]
7. Preformulation study of the inclusion complex warfarin-beta-cyclodextrin. Zingone G; Rubessa F Int J Pharm; 2005 Mar; 291(1-2):3-10. PubMed ID: 15707726 [TBL] [Abstract][Full Text] [Related]
8. Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir. Aleem O; Kuchekar B; Pore Y; Late S J Pharm Biomed Anal; 2008 Jul; 47(3):535-40. PubMed ID: 18367363 [TBL] [Abstract][Full Text] [Related]
9. Novel inclusion complex of ibuprofen tromethamine with cyclodextrins: physico-chemical characterization. Al Omari MM; Daraghmeh NH; El-Barghouthi MI; Zughul MB; Chowdhry BZ; Leharne SA; Badwan AA J Pharm Biomed Anal; 2009 Oct; 50(3):449-58. PubMed ID: 19545961 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of gastric toxicity of indomethacin acid, salt form and complexed forms with hydroxypropyl-beta-cyclodextrin on Wistar rats: histopathologic analysis. Ribeiro-Rama AC; Figueiredo IV; Veiga F; Castel-Branco MM; Cabrita AM; Caramona MM Fundam Clin Pharmacol; 2009 Dec; 23(6):747-55. PubMed ID: 19656206 [TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin. Liu L; Zhu S J Pharm Biomed Anal; 2006 Jan; 40(1):122-7. PubMed ID: 16095859 [TBL] [Abstract][Full Text] [Related]
12. Correlation and in vitro studies on radioactive and nonradioactive albendazole-beta-cyclodextrin complex tablets. Cetin EO; Ilem D; Gundogdu E; Asikoglu M; Kirilmaz L Pharmazie; 2011 Sep; 66(9):672-6. PubMed ID: 22026122 [TBL] [Abstract][Full Text] [Related]
13. Influence of cyclodextrin complexation on piroxicam gel formulations. Jug M; Bećirević-Laćan M; Kwokal A; Cetina-Cizmek B Acta Pharm; 2005 Sep; 55(3):223-36. PubMed ID: 16375834 [TBL] [Abstract][Full Text] [Related]
14. Analysis of triclosan inclusion complexes with β-cyclodextrin and its water-soluble polymeric derivative. Jug M; Kosalec I; Maestrelli F; Mura P J Pharm Biomed Anal; 2011 Apr; 54(5):1030-9. PubMed ID: 21215544 [TBL] [Abstract][Full Text] [Related]
15. Crystal structure of the inclusion complex of the antibacterial agent triclosan with cyclomaltoheptaose and NMR study of its molecular encapsulation in positively and negatively charged cyclomaltoheptaose derivatives. Paulidou A; Maffeo D; Yannakopoulou K; Mavridis IM Carbohydr Res; 2008 Oct; 343(15):2634-40. PubMed ID: 18684438 [TBL] [Abstract][Full Text] [Related]
16. Dissolution properties and characterization of halofantrine-2-hydroxypropyl-beta-cyclodextrin binary systems. Onyeji CO; Omoruyi SI; Oladimeji FA Pharmazie; 2007 Nov; 62(11):858-63. PubMed ID: 18065103 [TBL] [Abstract][Full Text] [Related]
17. Study of freeze-dried quercetin-cyclodextrin binary systems by DSC, FT-IR, X-ray diffraction and SEM analysis. Pralhad T; Rajendrakumar K J Pharm Biomed Anal; 2004 Feb; 34(2):333-9. PubMed ID: 15013147 [TBL] [Abstract][Full Text] [Related]
18. Study of branched cationic beta-cyclodextrin polymer/indomethacin complex and its release profile from alginate hydrogel. Xin J; Guo Z; Chen X; Jiang W; Li J; Li M Int J Pharm; 2010 Feb; 386(1-2):221-8. PubMed ID: 19945520 [TBL] [Abstract][Full Text] [Related]
19. Preparation of amorphous indomethacin from aqueous 2,6-di-O-methyl-beta-cyclodextrin solution. Iohara D; Hirayama F; Ishiguro T; Arima H; Uekama K Int J Pharm; 2008 Apr; 354(1-2):70-6. PubMed ID: 18093762 [TBL] [Abstract][Full Text] [Related]
20. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles. Fini A; Cavallari C; Ospitali F Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]